These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15803572)

  • 1. RA drugs Enbrel, Humira appear safe.
    Health News; 2005 Mar; 11(3):9. PubMed ID: 15803572
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatoid arthritis drugs show promise.
    Mayo Clin Health Lett; 1999 Jan; 17(1):4. PubMed ID: 9919935
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
    Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
    Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
    [No Abstract]   [Full Text] [Related]  

  • 4. [Emergence of new therapeutic agents for collagen diseases and some of the problems].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1990-6. PubMed ID: 14621590
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
    Moreland LW
    J Rheumatol Suppl; 1999 May; 57():7-15. PubMed ID: 10328137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B
    J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [When are "biologics" indicated?].
    MMW Fortschr Med; 2006 Apr; 148(17):10. PubMed ID: 16711479
    [No Abstract]   [Full Text] [Related]  

  • 9. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs.
    Konttinen YT; Seitsalo S; Lehto M; Santavirta S
    Acta Orthop; 2005 Oct; 76(5):614-9. PubMed ID: 16263606
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.
    Watanabe T; Tanigawa T; Shiba M; Nadatani Y; Nagami Y; Sugimori S; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Koike T; Arakawa T
    Gut; 2014 Mar; 63(3):409-14. PubMed ID: 23697473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatoid arthritis: current status of therapy].
    El Bahri DM; Meddeb N; Sellami S
    Tunis Med; 2007 Jan; 85(1):1-8. PubMed ID: 17424701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs for rheumatoid arthritis.
    Olsen NJ; Stein CM
    N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-TNF-alpha therapies: they are all the same (aren't they?).
    Mpofu S; Fatima F; Moots RJ
    Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
    [No Abstract]   [Full Text] [Related]  

  • 14. [TNF-alpha inhibitors and demyelinating disease].
    Böttiger Y
    Lakartidningen; 2007 Nov 7-13; 104(45):3384. PubMed ID: 18062640
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis.
    Bullano MF; McNeeley BJ; Yu YF; Quimbo R; Burawski LP; Yu EB; Woolley JM
    Manag Care Interface; 2006 Sep; 19(9):47-53. PubMed ID: 17017313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
    Hyrich KL; Silman AJ
    J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
    [No Abstract]   [Full Text] [Related]  

  • 17. New drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1998 Nov; 40(1040):110-2. PubMed ID: 9844625
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
    J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
    Tomono K; Hashimoto S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.